JBIO
Jade Biosciences
JBIO
JBIO
105 hedge funds and large institutions have $726M invested in Jade Biosciences in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 44 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
35% more funds holding
Funds holding: 78 → 105 (+27)
1.45% less ownership
Funds ownership: 96.91% → 95.46% (-1.4%)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $1.76M
Holders
105
Holding in Top 10
5
Calls
$3K
Puts
$1.76M
Top Buyers
| 1 | +$39.2M | |
| 2 | +$30.6M | |
| 3 | +$23.5M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$19.3M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$15.6M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$12.2M | |
| 3 | -$4.58M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.32M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.7M |
